Table 3 PPARδ (a) and miR-17 (b) expression levels (median RQ values) in individual NSCLC tissue group and control group.
From: Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer
Features | NSCLC tissue | p-value Mann Whitney U-test | Macroscopically unchanged tissue (control) | p-value Mann Whitney U-test |
|---|---|---|---|---|
(a) PPARδ | ||||
≤ 65 years | 0.816 | 0.5892 | 1.959 | 0.8170 |
> 65 years | 0.668 | 1.451 | ||
Women | 0.842 | 0.2535 | 1.414 | 0.1611 |
Men | 0.643 | 2.430 | ||
Former smokers | 0.791 | 0.1627 | 1.368 | 0.0200* |
Current smokers | 0.637 | 2.528 | ||
≤ 40 PYs | 0.683 | 0.2888 | 1.517 | 0.1086 |
> 40 PYs | 0.753 | 2.528 | ||
SCC | 0.688 | 0.3961 | 1.502 | 0.9385 |
AC | 0.842 | 1.762 | ||
T1 | 0.828 | 0.7771 | 1.811 | 0.6029 |
T2 + T3 | 0.692 | 1.517 | ||
N0 | 0.732 | 0.9594 | 1.714 | 0.6404 |
N1 + N2 | 0.692 | 1.414 | ||
I | 0.732 | 0.7988 | 1.714 | 0.6404 |
II + III | 0.692 | 1.517 | ||
(b) miR-17 | ||||
≤ 65 years | 12.949 | 0.5892 | 44.369 | 0.4875 |
> 65 years | 19.484 | 26.996 | ||
Women | 12.881 | 0.6038 | 33.655 | 0.9586 |
Men | 20.704 | 39.561 | ||
Former smokers | 20.704 | 0.8481 | 27.760 | 0.5290 |
Current smokers | 15.226 | 43.933 | ||
≤ 40 PYs | 11.836 | 0.1211 | 23.748 | 0.6833 |
> 40 PYs | 22.200 | 40.288 | ||
SCC | 20.968 | 0.2076 | 24.638 | 0.0422* |
AC | 9.319 | 50.615 | ||
T1 | 13.017 | 0.9550 | 39.561 | 0.9539 |
T2 + T3 | 18.264 | 33.655 | ||
N0 | 12.881 | 0.3302 | 33.655 | 0.7555 |
N1 + N2 | 21.232 | 41.016 | ||
I | 13.017 | 0.8785 | 39.561 | 0.5681 |
II + III | 18.264 | 27.760 | ||
